Understanding the landscape to expand, strengthen, and diversify African-based manufacturing
In 2022, more than 8,000 people in the Kyrgyz Republic developed tuberculosis (TB), including
India is often referred to as the ‘pharmacy of the world’ and is undeniably the leading manufacturing hub for many of the world’s most essential medicines.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at events taking place around the globe in recent months and will continue to do so throughout 2023.
Hundreds of global public health experts converged in late May 2023 in Geneva, Switzerland for the 76th meeting of the World Health Assembly (WHA), the decision-making body of the World Health Organization (WHO).
Substandard medicines are a huge public health threat. Proactively evaluating drug products using a relative risk assessment is important to reduce the prevalence of substandard antibiotics.
How to secure upstream pharmaceutical supply chain risks with data and advanced technologies to increase access to quality medical products for patients
Show 11 More